Back
Nutex Health Vs. National Research Industry Stock Comparison
Buy
58
NUTX
Nutex Health
Last Price:
32.98
Seasonality Move:
-16.36%
Sell
30
NRC
National Research
Last Price:
19.46
Seasonality Move:
-0.82%
Buy
58
Nutex Health (NUTX)
is a Buy
Is Nutex Health a Buy, Sell or Hold?
- The current Nutex Health [NUTX] share price is $32.62. The Score for NUTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- NUTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
National Research (NRC)
is a Sell
Is National Research a Buy, Sell or Hold?
- The current National Research [NRC] share price is $20.30. The Score for NRC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NRC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUTX Stock Price Chart
What is Nutex Health's stock price today?
-
The Nutex Health share price today is $32.62
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUTX is experiencing selling pressure, which indicates risk of future bearish movement.
NRC Stock Price Chart
What is National Research's stock price today?
-
The National Research share price today is $20.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRC is experiencing slight buying pressure.
NUTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.83 | Buy |
Relative Strength Index (14 RSI): | 62.26 | Buy |
Chaikin Money Flow: | -85516 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20 - 28.76) | Buy |
Bollinger Bands (100): | (8.72 - 24.98) | Buy |
NRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 55.07 | Buy |
Chaikin Money Flow: | 4606 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.2 - 20) | Buy |
Bollinger Bands (100): | (19.66 - 23.6) | Sell |
NUTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.14 | Buy |
20-day SMA: | 25.59 | Buy |
50-day SMA: | 23.17 | Buy |
200-day SMA: | 14.02 | Buy |
8-day EMA: | 29.96 | Buy |
20-day EMA: | 26.54 | Buy |
50-day EMA: | 22.9 | Buy |
200-day EMA: | 24.52 | Buy |
NRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.99 | Buy |
20-day SMA: | 19.12 | Buy |
50-day SMA: | 20.33 | Sell |
200-day SMA: | 28.23 | Sell |
8-day EMA: | 19.99 | Buy |
20-day EMA: | 19.61 | Buy |
50-day EMA: | 20.32 | Sell |
200-day EMA: | 26.85 | Sell |
Nutex Health Earnings Growth & NUTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $1.74 per share.
National Research Earnings Growth & NRC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nutex Health Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
National Research Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |